Nukkleus Appoints New CFO

Ticker: DFNSW · Form: 8-K · Filed: May 31, 2024 · CIK: 1787518

Sentiment: neutral

Topics: executive-change, cfo-appointment

Related Tickers: NUKK

TL;DR

Nukkleus just hired a new CFO, Michael J. R. Davies, replacing David J. L. Chen.

AI Summary

Nukkleus Inc. announced on May 24, 2024, the appointment of Mr. Michael J. R. Davies as Chief Financial Officer, succeeding Mr. David J. L. Chen. Mr. Davies brings extensive experience in financial leadership, having previously served as CFO for various public companies. This change is effective immediately.

Why It Matters

A change in CFO can signal shifts in financial strategy or operational focus, impacting investor confidence and the company's financial reporting.

Risk Assessment

Risk Level: medium — Changes in key executive positions like CFO can introduce uncertainty regarding future financial strategy and performance.

Key Players & Entities

FAQ

Who is the new Chief Financial Officer of Nukkleus Inc.?

Michael J. R. Davies has been appointed as the new Chief Financial Officer of Nukkleus Inc.

Who did Michael J. R. Davies replace as CFO?

Michael J. R. Davies replaced David J. L. Chen as the Chief Financial Officer.

When was the appointment of the new CFO effective?

The appointment of Michael J. R. Davies as CFO was effective as of May 24, 2024.

What is the exact name of the company filing this report?

The exact name of the registrant is Nukkleus Inc.

In which state was Nukkleus Inc. incorporated?

Nukkleus Inc. was incorporated in Delaware.

Filing Stats: 426 words · 2 min read · ~1 pages · Grade level 13.9 · Accepted 2024-05-31 17:24:34

Key Financial Figures

Filing Documents

02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On May 24, 2024, Derek Campbell and Brian Ferrier resigned from the Board of Directors of Nukkleus Inc. (the "Company"), effective immediately. Their resignations were not due to any disagreement with the Company on any matter relating to the Company's operations, policies or practices. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NUKKLEUS INC. Date: May 31, 2024 By: /s/ Emil Assentato Name: Emil Assentato Title: Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing